Mechanisms of interaction between a phosphoinositide anticoagulant and a phospholipid activator in the Stypven type conversion of prothrombin to thrombin.
D000925:Anticoagulants / Q000494:pharmacology*; D001777:Blood Coagulation / Q000187:drug effects*; D002118:Calcium / Q000378:metabolism; D005165:Factor V / Q000378:metabolism; D005170:Factor X / Q000378:metabolism; D010716:Phosphatidylinositols / Q000494:pharmacology*; D010743:Phospholipids / Q000378:metabolism; D011516:Prothrombin / Q000378:metabolism*; D013917:Thrombin; D014688:Venoms
D000925:Anticoagulants; D010716:Phosphatidylinositols; D010743:Phospholipids; D014688:Venoms; D005165:Factor V; D011516:Prothrombin; D005170:Factor X; D013917:Thrombin; D002118:Calcium